Nissan Chemical Corporation, known for innovative research efforts and high‑quality products in a wide range of sectors, is seeking novel biomarker‑guided approaches for the diagnosis of dementia from biopsy samples. Successful approaches should provide simultaneous analysis of multiple markers, offering high sensitivity and selectivity.
Approaches of Interest:
- Minimally invasive diagnostic procedures offering the detection of multiple dementia biomarkers in biopsy samples including blood, plasma, sweat, tears, breath, or CSF.
- Screening and detection of...